Search Results - David M. Schuster

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Detection Rates of PSMA-PET Radiopharmaceuticals in Recurrent Prostate Cancer: A Systematic Review by Soroush Rais-Bahrami, Phillip Davis, Albert Chau, Samuel J. Galgano, Brian F. Chapin, David M. Schuster, Catriona M. Turnbull

    Published in Diagnostics (2025-05-01)
    Get full text
    Article


  2. 2

    Lesion segmentation on 18F-fluciclovine PET/CT images using deep learning by Tonghe Wang, Tonghe Wang, Yang Lei, Eduard Schreibmann, Justin Roper, Tian Liu, David M. Schuster, Ashesh B. Jani, Xiaofeng Yang

    Published in Frontiers in Oncology (2023-12-01)
    Get full text
    Article


  3. 3

    [18F]Fluciclovine PET discrimination between high- and low-grade gliomas by Ephraim E. Parent, Marc Benayoun, Ijeoma Ibeanu, Jeffrey J. Olson, Constantinos G. Hadjipanayis, Daniel J. Brat, Vikram Adhikarla, Jonathon Nye, David M. Schuster, Mark M. Goodman

    Published in EJNMMI Research (2018-07-01)
    Get full text
    Article


  4. 4

    Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study by Benjamin H. Lowentritt, MD, Ashesh B. Jani, MD, Brian T. Helfand, MD, Edward M. Uchio, MD, Michael A. Morris, MD, Jeff M. Michalski, MD, Albert Chau, MSc, Phillip Davis, MD, Brian F. Chapin, MD, David M. Schuster, MD

    Published in Advances in Radiation Oncology (2024-08-01)
    Get full text
    Article


Search Tools: